Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cleo Lee

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Biotechnology|July 12, 2011
Targeted oncolytic herpes simplex viruses for aggressive cancersJennifer Wong, Cleo Lee, Kevin Zhang, et al.
Oncotarget|April 13, 2016
Tumour-specific triple-regulated oncolytic herpes virus to target gliomaZahid M Delwar, Guoyu Liu, Yvonne Kuo, et al.
International Journal of Cancer|December 4, 2009
Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell deathKai-xin Zhang, Yoshiyuki Matsui, Boris A Hadaschik, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Biotechnology|July 12, 2011
Targeted oncolytic herpes simplex viruses for aggressive cancersJennifer Wong, Cleo Lee, Kevin Zhang, et al.
Oncotarget|April 13, 2016
Tumour-specific triple-regulated oncolytic herpes virus to target gliomaZahid M Delwar, Guoyu Liu, Yvonne Kuo, et al.
International Journal of Cancer|December 4, 2009
Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell deathKai-xin Zhang, Yoshiyuki Matsui, Boris A Hadaschik, et al.
Pageof 1